z-logo
Premium
Myoclonic epilepsy of lafora and arylsulphatase a deficiency in the same patient
Author(s) -
Bertagnolio B.,
Girotti F.,
Pelucchetti D.,
Pandolfo M.
Publication year - 1989
Publication title -
journal of inherited metabolic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1007/bf01802043
Subject(s) - cerebroside , lafora disease , endocrinology , medicine , heterozygote advantage , compound heterozygosity , loss of heterozygosity , gene , biology , genetics , genotype , mutation , biochemistry , enzyme , allele , phosphatase
Summary Very low levels of arylsulphatase A were found in a young patient with the clinical features of Lafora disease, confirmed by muscle biopsy. The deficiency was shown both in leukocytes and cultured fibroblasts. A cerebroside sulphate loading showed that 93% of [ 14 C]cerebroside sulphate taken up by skin fibroblasts from the patient remained unmetabolized after a 24 h pulse, ruling out pseudo‐arylsulphatase A deficiency. In the healthy parents and siblings of the patient, biochemical data suggested heterozygosity for arylsulphatase A deficiency. The apparent co‐inheritance of arylsulphatase A deficiency and Lafora disease in this family might be the consequence of genetic linkage between the two genes.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here